v3.21.2
Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities (Details) - USD ($)
shares in Thousands, $ in Millions
6 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share (in shares) 13,830 20,064
Contingent consideration related to business combinations $ 11.4  
Contingent consideration vesting period 2 years  
Shares of common stock subject to repurchase from outstanding stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share (in shares) 369 728
RSUs and PSUs subject to future vesting    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share (in shares) 8,019 8,311
Shares of common stock issuable from stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share (in shares) 4,867 9,871
Share purchase rights under the employee stock purchase plan    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential common shares excluded from diluted net loss per share (in shares) 575 1,154